Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background and purpose: Whilst there is evidence implicating small vessel cerebrovascular disease in the pathogenesis of Alzheimer's disease (AD), its specific contribution to the pathophysiology of AD remains unclear. The burden of small vessel cerebrovascular disease visualized as white matter hyperintensity (WMH) and its association with medial temporal atrophy (MTA) at different stages of AD was studied. Methods: One hundred and sixty‐five cognitively normal (CN) community controls, 103 mild cognitive impairment (MCI) patients, 141 mild AD patients and 68 moderate−severe AD patients were studied. Clinical, cognitive and risk factor data were collected, and WMH and MTA were quantified by trained raters. The Jonckheere−Terpstra test for ordered alternatives was used to study the association between WMH and MTA in different stages of AD. Results: The burden of total WMH increased significantly with increasing severity of AD, even after correcting for confounders. The proportion of CN, MCI, mild AD and moderate−severe AD subjects with severe burden of WMH was 6.7%, 9.7%, 28.4%, and 39.7%, respectively. A strong positive association between WMH severity and MTA was evident amongst MCI (P = 0.011) and mild AD (P = 0.003) subjects, but not in CN (P = 0.953) and moderate−severe AD subjects (P = 0.301). Conclusions: The burden of WMH increased significantly from the stage of CN to MCI to AD. The association between WMH and MTA was greatest at the stage of MCI and mild AD. This has implications on the strategy to slow the progression of AD, where measures to reduce WMH, including control of vascular risk factors, need to be optimized at the stage of MCI and mild AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Au, R., Massaro, J. M., Wolf, P. A., Young, M. E., Beiser, A., Seshadri, S., D’Agostino, R. B., & DeCarli, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.246 · Cited by 381
Carmichael, O. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.284 · Cited by 248
White, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1178 · Cited by 193
Provenzano, F. A., Muraskin, J., Tosto, G., Narkhede, A., Wasserman, B. T., Griffith, E. Y., Guzman, V. A., Meier, I. B., Zimmerman, M. E., Brickman, A. M., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1321 · Cited by 192 · cited 1×
“loid-positive status at baseline conferred risk for future diagnosis of AD [25].”
BackgroundCoevolution of white matter hyperintensities and cognition in the elderly
Maillard, P., Carmichael, O., Fletcher, E., Reed, B., Mungas, D., & DeCarli, C. (2012) · Neurology · doi:10.1212/wnl.0b013e3182617136 · Cited by 172 · cited 1×
“disease to be higher in AD compared with elderly controls [3].”
BackgroundVascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b9d · Cited by 156
Cited by
Qiu, L., Ng, G., Tan, E. K., Liao, P., Kandiah, N., & Zeng, L. (2016) · Scientific Reports · doi:10.1038/srep23964 · Cited by 115
Self-citationMETACOHORTS Consortium, Dichgans, M., Wardlaw, J., Smith, E., Zietemann, V., Seshadri, S., Sachdev, P., Biessels, G. J., Fazekas, F., Benavente, O., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.004 · Cited by 101
“For example, larger studies at different disease stages across multiple clinics would help to determine if white matter hyperintensity (WMH) burden is indeed a stronger predictor of progressive brain atrophy in people with MCI and early AD than in later stages [28,29].”
Roseborough, A. D., Saad, L., Goodman, M., Cipriano, L. E., Hachinski, V. C., & Whitehead, S. N. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12642 · Cited by 80
Vipin, A., Kumar, D., Soo, S. A., Zailan, F. Z., Leow, Y. J., Koh, C. L., Ng, A. S. L., Ng, K. P., & Kandiah, N. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01251-4 · Cited by 17
Self-citationKumar, D., Yatawara, C., Wang, B., Wong, B., Tan, Y. J., Zailan, F. Z., Ng, K. P., & Kandiah, N. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215556 · Cited by 12
Self-citation
Metadata
- Authors
- Kandiah, N., Chander, R. J., Ng, A., Wen, M. C., Cenina, A. R., & Assam, P. N.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2014-08-21
- Volume
- 22
- Issue
- 1
- Pages
- 150-155
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W1976949993
- Cited by
- 38
- References
- 6
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease. https://app.cochat.ai/papers/10.1111/ene.12546
- The paper
- Kandiah, N., Chander, R. J., Ng, A., Wen, M. C., Cenina, A. R., & Assam, P. N. (2015). Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease. European Journal of Neurology. https://doi.org/10.1111/ene.12546
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.